NO983947D0 - Anvendelse av 2-(3,4-dimetoksycinnamoyl)-aminbenzosyre ved fremstilling av et medikament for behandling eller forebygging av restenose - Google Patents

Anvendelse av 2-(3,4-dimetoksycinnamoyl)-aminbenzosyre ved fremstilling av et medikament for behandling eller forebygging av restenose

Info

Publication number
NO983947D0
NO983947D0 NO983947A NO983947A NO983947D0 NO 983947 D0 NO983947 D0 NO 983947D0 NO 983947 A NO983947 A NO 983947A NO 983947 A NO983947 A NO 983947A NO 983947 D0 NO983947 D0 NO 983947D0
Authority
NO
Norway
Prior art keywords
dimethoxycinnamoyl
restenosis
medicament
prevention
manufacture
Prior art date
Application number
NO983947A
Other languages
English (en)
Norwegian (no)
Inventor
Juichi Fukuyama
Keiji Miyazawa
Arao Ujiie
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25101171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO983947(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NO983947D0 publication Critical patent/NO983947D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO983947A 1996-12-30 1998-08-27 Anvendelse av 2-(3,4-dimetoksycinnamoyl)-aminbenzosyre ved fremstilling av et medikament for behandling eller forebygging av restenose NO983947D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/774,418 US6019104A (en) 1996-12-30 1996-12-30 Method for the treatment or prevention of restenosis associated with coronary intervention
PCT/JP1997/004698 WO1998029104A2 (en) 1996-12-30 1997-12-19 Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the manufacture of a medicament for the treatment or prevention of restenosis

Publications (1)

Publication Number Publication Date
NO983947D0 true NO983947D0 (no) 1998-08-27

Family

ID=25101171

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983947A NO983947D0 (no) 1996-12-30 1998-08-27 Anvendelse av 2-(3,4-dimetoksycinnamoyl)-aminbenzosyre ved fremstilling av et medikament for behandling eller forebygging av restenose

Country Status (19)

Country Link
US (1) US6019104A (hu)
EP (1) EP0891185A2 (hu)
KR (1) KR19990087396A (hu)
CN (1) CN1220599A (hu)
AR (1) AR009446A1 (hu)
AU (1) AU7854198A (hu)
BR (1) BR9707877A (hu)
CA (1) CA2247306A1 (hu)
CZ (1) CZ251198A3 (hu)
EA (1) EA001931B1 (hu)
HU (1) HUP9904029A3 (hu)
ID (1) ID20165A (hu)
IL (1) IL125660A0 (hu)
NO (1) NO983947D0 (hu)
NZ (1) NZ331338A (hu)
PE (1) PE27399A1 (hu)
TR (1) TR199801698T1 (hu)
WO (1) WO1998029104A2 (hu)
ZA (1) ZA9711719B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4583597B2 (ja) * 1998-05-05 2010-11-17 ボストン サイエンティフィック リミテッド 末端が滑らかなステント
CA2361581A1 (en) * 1999-02-03 2000-08-10 Smithkline Beecham Corporation Method for the prevention or reduction of cariovascular events associated with coronary intervention
JP2002536326A (ja) * 1999-02-03 2002-10-29 スミスクライン・ビーチャム・コーポレイション 冠状動脈インターベンションに伴う心臓血管事象の予防または軽減方法
AU2001243248A1 (en) * 2000-02-23 2001-09-03 Smith Kline Beecham Corporation Method for the prevention or reduction of vascular access dysfunction
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070484A (en) * 1973-01-18 1978-01-24 Kissei Pharmaceutical Co., Ltd. Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
JPS5640710B2 (hu) * 1973-01-18 1981-09-22
US4337270A (en) * 1980-05-21 1982-06-29 Hisamitsu Pharmaceutical Co., Inc. Novel anthranilic acid derivatives
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤

Also Published As

Publication number Publication date
ID20165A (id) 1998-10-15
US6019104A (en) 2000-02-01
CN1220599A (zh) 1999-06-23
HUP9904029A3 (en) 2000-11-28
NZ331338A (en) 2000-12-22
BR9707877A (pt) 1999-07-27
EA199800781A1 (ru) 1999-12-29
PE27399A1 (es) 1999-03-31
EP0891185A2 (en) 1999-01-20
WO1998029104A2 (en) 1998-07-09
CA2247306A1 (en) 1998-07-09
EA001931B1 (ru) 2001-10-22
TR199801698T1 (xx) 1999-03-22
WO1998029104A3 (en) 1998-10-01
IL125660A0 (en) 1999-04-11
ZA9711719B (en) 1998-06-25
CZ251198A3 (cs) 1999-08-11
AU7854198A (en) 1998-07-31
AR009446A1 (es) 2000-04-12
KR19990087396A (ko) 1999-12-27
HUP9904029A2 (hu) 2000-05-28

Similar Documents

Publication Publication Date Title
HK1005425A1 (en) Use of 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the manufacture of a medicament for the treatment of restenosis
IT1284108B1 (it) Presidio chirurgico per il trattamento dell'enfisema polmonare
BR9504450A (pt) Agentes herbicidas processo para o combate de ervas daninhas utilizaçao e processo para a preparaçao de agentes herbicidas
FI953915A (fi) Dupuytrenin taudin lievittämiseen
NO973243D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer
NO20021969L (no) Gassfase-polymerisasjonsprosess
AU4008597A (en) The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
NO962752D0 (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
WO1998018440A3 (fr) Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles
NO983947D0 (no) Anvendelse av 2-(3,4-dimetoksycinnamoyl)-aminbenzosyre ved fremstilling av et medikament for behandling eller forebygging av restenose
PT1152762E (pt) Utilizacao de desoxipeganina no tratamento da demencia de alzheimer
DE69528637D1 (de) Hautbehandlungsmittel gegen akne
ITTN990006V0 (it) Nuovo sistema di confezionamento per un piu' corretto e sicuro utilizz o del preservativo - profilattico
IT1271417B (it) Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.
IL126068A0 (en) The use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substances on the heart
DE69713128D1 (de) 4-(1-piperazinyl)benzosäurederivate, verfahren zu ihrer herstellung und ihre therapeutischen verwendungen
FI953725A0 (fi) Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi
IL123422A0 (en) Use of 7alpha-methyl-17alpha-ethynyl-estrane derivatives for the manufacture of a medicament for the prophylaxis or the treatment of atherosclerosis
EE200200128A (et) Dekstrasoksaani kasutamine, produkt ja meetod psoriaasi raviks mõeldud ravimi valmistamiseks
IL130103A0 (en) The use of a diarylalkane derivative in the manufacture of a medicament for treatment or prevention of pancreatitis
HUP0200148A3 (en) Use of n-(3',4'-dimethoxy-cinnamoyl)-anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention
RU99123655A (ru) Средство для лечения герпеса
HUP0200129A3 (en) Use of n-(3'4'-dimethoxycinnamoyl) anthranilic acid for the prevention or reduction of cardiovascular events associated with coronary intervention
ITBO990233A0 (it) Apparecchiatura per l' applicazione di una banda sul profilo periferic o circolare di un articolo .
RU99115205A (ru) Способ оперативного лечения синдрома повреждения илиотибиального тракта